NCT03668366View on ClinicalTrials.gov

S-1 Combined With IMRT Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

133

Participants

Timeline

Start Date

August 1, 2013

Primary Completion Date

December 1, 2018

Study Completion Date

August 1, 2020

Conditions
Nasopharyngeal Carcinoma
Interventions
DRUG

S-1

The patients will receive IMRT combined with S-1 concurrent chemoradiotherapy. The specific treatment description is included in arm description.

Trial Locations (1)

200032

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER

NCT03668366 - S-1 Combined With IMRT Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma | Biotech Hunter | Biotech Hunter